OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
19
Results
Show all
Save search
Copy query
Show results for
Unknown
(19)
Publication Date
Release Date
2021
(7)
2022
(4)
2025
(3)
2023
(2)
2024
(1)
2019
(1)
2011
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Evaluation of cardiovascular risk in a lung cancer screening cohort.
Not available
S-EPMC6902068
|
biostudies-literature
Cite
Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis.
Not available
S-EPMC8589726
|
biostudies-literature
Cite
ELFN1 deficiency: The mechanistic basis and phenotypic spectrum of a neurodevelopmental disorder with epilepsy.
Not available
S-EPMC12260708
|
biostudies-literature
Cite
Joint, multifaceted genomic analysis enables diagnosis of diverse, ultra-rare monogenic presentations.
Not available
S-EPMC12328722
|
biostudies-literature
Cite
Stereoacuity in children with anisometropic amblyopia.
Not available
S-EPMC3223370
|
biostudies-literature
Cite
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931
|
biostudies-literature
Cite
Dexamethasone in Hospitalized Patients with Covid-19.
Not available
S-EPMC7383595
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets